Drug Re-Purposing for Use in the Alzheimer’s Population

Description: An overview of the therapeutic potential of repurposed drugs in treating Alzheimer’s disease, with discussion of clinical trials for several possible treatments using repurposed drugs
Runtime: 00:27:19

Speaker: Barry D. Greenberg, PhD
Speaker title: Director, Neuroscience Drug Discovery and Development
Speaker organization: University Health Network, Toronto

Event: 2016 DIAD Family Conference: Too Young to Forget
Location: Toronto, Ontario, Canada
Year: 2016

Search tags: drug development, drug repurposing, clinical trials, risk and safety, Levetiracetam, cognitive impairment, APOE4, preclinical Alzheimer’s, HOPE4MCI Trial, public-private partnership, Telmisartan, disease modification, Sartan-AD Trial, Montelukast